← Leaderboards
Johannes Koch
University Of California San Francisco
$564
Attributed
$564
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$564 · 2
By mechanism
M01$564 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Melvin B. Heyman$7,841,306
- Alan S Verkman$35,167,321
- Elizabeth A. Holly$9,670,909
- Frederic M. Waldman$7,639,095
- Lily Y Jan$24,385,637
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchColon NeoplasmsCancer PreventionBreast NeoplasmsNeoplasm /Cancer DiagnosisNeoplasm /Cancer EpidemiologyHuman DataProstate NeoplasmsHuman SubjectHuman Therapy EvaluationInhibitor /AntagonistIon TransportGastrointestinal Disorder ChemotherapyChloride IonDiarrheaDrug Screening /EvaluationGastrointestinal Absorption /TransportGastrointestinal AgentsAids TherapyHiv Infections
Grant awards (7)
SCREENING AND REFERRAL PRACTICES FOR CANCER DETECTION$0
M01 · FY2002 · RR
SCREENING AND REFERRAL PRACTICES FOR CANCER DETECTION$0
M01 · FY2002 · RR
SCREENING AND REFERRAL PRACTICES FOR CANCER DETECTION$0
M01 · FY2001 · RR
STUDY TO ASSESS THE SAFETY AND EFFICACY OF SP-303 IN PATIENTS WITH AIDS DIARRHEA$564
M01 · FY2000 · RR
SCREENING AND REFERRAL PRACTICES FOR CANCER DETECTION$0
M01 · FY2000 · RR
SCREENING AND REFERRAL PRACTICES FOR CANCER DETECTION$0
M01 · FY2000 · RR
SCREENING AND REFERRAL PRACTICES FOR CANCER DETECTION$0
M01 · FY2000 · RR